The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
about
Long-term effects of weight-reducing drugs in people with hypertensionLong-term effects of weight-reducing diets in people with hypertensionCardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesExercise for Hypertension: A Prescription Update Integrating Existing Recommendations with Emerging ResearchAmbulatory care after acute kidney injury: an opportunity to improve patient outcomesAcute kidney injury: preclinical innovations, challenges, and opportunities for translationDiabetes and Hypertension: A Comparative Review of Current GuidelinesUpdated national and international hypertension guidelines: a review of current recommendationsAcute hypertension: a systematic review and appraisal of guidelinesDevelopment and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods studySystolic BP and Mortality in Older Adults with CKD.US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the FutureRole of echocardiography in clinical hypertensionTherapy: atenolol versus metoprolol tartrate--conflicting outcomes data.Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial.The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study.Assessment and management of resistant hypertensionThe comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases.Factors associated with grade 1 hypertension: implications for hypertension care based on the Dietary Approaches to Stop Hypertension (DASH) in primary care settings.Hypotensive response magnitude and duration in hypertensives: continuous and interval exercise.Labetalol for hypertension in pregnancy.Does pragmatically structured outpatient dietary counselling reduce sodium intake in hypertensive patients? Study protocol for a randomized controlled trial.Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial.Managing atrial fibrillation.How Accurate Are Home Blood Pressure Devices in Use? A Cross-Sectional StudyAssociation of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.AT1-receptor response to non-saturating Ang-II concentrations is amplified by calcium channel blockersThe Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults.Assessment of a hypertension screening and education intervention in Charlestown, Guyana: Hypertension Evaluation & Learning Program (HELP).Unpacking the Black Box: A Formative Research Approach to the Development of Theory-Driven, Evidence-Based, and Culturally Safe Text Messages in Mobile Health Interventions.Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study.Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic reviewEplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndromeHypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivololPredicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP): Derivation and Validation of a Tool to Improve the Accuracy of Blood Pressure Measurement in Clinical Practice.Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savingsTarget organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.Sex and gender considerations in Canadian clinical practice guidelines: a systematic reviewThe role of adiponectin in endothelial dysfunction and hypertension.Managing hypertension: evidence supporting the 2013/2014 recommendations of the Canadian Hypertension Education Program.
P2860
Q24186054-B80E8062-2C28-4942-9589-1DC280BBDCA9Q24186055-B7DC7DE5-1355-44B8-B795-B95DAD5D6D50Q26767278-12C3E7D2-8D89-4A49-BE53-71B6D04C8260Q26783924-91C826E5-BEE4-4F93-9416-9D158833A34AQ26786492-337AE16B-CADA-402E-9385-631D10A9B923Q26786667-FC17B200-ABA9-4336-9B86-EDF8B9289D73Q26800179-9A2D6D81-F941-47C8-BE45-6FCBD070CE99Q26824589-4EACC448-4784-4584-9E22-C8B5B6F50BD6Q27011845-AEBDC551-0A99-4E75-B022-8A719404E93CQ27307648-420B0F57-C010-4F47-9059-505FBB8185C4Q27335475-E191159E-661F-4383-993D-6B945DCC3631Q28081091-1C52EA5D-7607-4B9B-9481-2EBA6C9FAFFEQ30390785-1316B256-C1DB-40E6-9F9F-E60DB44C89C8Q30848706-C4FA0CD4-D049-41BC-8BC9-4848E1FE57CFQ33167337-49C5EC33-D9EF-4BA5-B5AA-3446B48AE9ADQ33874896-886A7724-0DD7-4F97-9F22-CC8BA6C92650Q34656780-818E7BFA-0F66-427D-BE39-9A417EDE2520Q35001942-ECE07DF3-43FE-446A-BE58-43F3ED3A7181Q35150599-2D7DD80A-2FE0-42E5-95BD-403E13BB6BE1Q35285159-5DAA49A7-2027-4A2C-85C8-0F922A9D827AQ35563333-5A6C9BA8-5538-43C9-AF55-D0FE5EC0B283Q35776205-B7A4F6C6-EE19-41A4-A05B-9CA460BE048DQ35865704-A3FF2EE7-3DEC-4ECB-9110-7FA357DC6A38Q35900515-733D3C1E-AFC0-43A8-9117-F0B10254429DQ36036316-C410146C-9AD2-44C2-839E-46AD727E0954Q36306359-476619AB-E88F-40AD-BD41-312694962A10Q36374225-96EBA1AF-1F30-41E1-A0EF-5A18A3922446Q36394802-291B9640-5C77-4060-85D1-80D60F5E09BFQ36465568-2DEDAFD3-422C-4AF3-9D6B-3D92811CD4C1Q36553037-C20B5319-F0DC-4F0B-B116-DC8630057F2BQ36676254-A216ADD7-8E93-4128-AD4E-665AB2C043F3Q36678123-0751EDC5-A111-4308-A594-DB16D1FA81C1Q36754659-4D846E29-DA47-474E-AFEB-E5C0AB881889Q36982759-0D7170C1-C808-49A7-B041-F146B69C4950Q36998681-1A200692-A789-46FB-9663-D2D665AE4FF5Q37174306-2D9A5281-11BF-48F4-A793-8DD913138BDCQ37452299-62442976-0553-4F7C-8912-4357A65C2848Q37735894-8B0FC9E9-CF9A-40C8-B756-752CC1E00FB6Q38219891-32642EF9-09BA-4726-AC51-1242457C85A4Q38260387-E670F165-FB29-4B16-941D-E55ED518BECE
P2860
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@ast
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@en
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@nl
type
label
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@ast
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@en
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@nl
prefLabel
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@ast
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@en
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@nl
P2093
P50
P1476
The 2014 Canadian Hypertension ...... and treatment of hypertension.
@en
P2093
Alain Milot
Ally Prebtani
Andrew Pipe
Canadian Hypertension Education Program
Charlotte Jones
Debra J Reid
Denis Drouin
Donald W McKay
Donna McLean
Doreen M Rabi
P304
P356
10.1016/J.CJCA.2014.02.002
P577
2014-02-22T00:00:00Z